GreenMark Biomedical
GreenMark: A healthcare firm providing nanoparticle solutions for early dental diagnosis and treatment.
Founded
2016GreenMark: A healthcare firm providing nanoparticle solutions for early dental diagnosis and treatment.
Founded with a mission to revolutionize dental care, GreenMark Biomedical focuses on providing nanoparticle solutions for early dental diagnosis and treatment. The company's vision is to transform the dental experience by offering non-invasive products that aid in the early detection and management of oral health issues. Their flagship product, CrystLCare™ Biorestorative, aims to treat dental sensitivity and enhance the visualization of caries disease, promoting painless and natural tooth repair. GreenMark targets dentists, hygienists, and patients seeking proactive and preventative oral health care solutions.
Notable figures affiliated with GreenMark Biomedical include experts in nanotechnology and dental care, although specific names are not provided. The company has garnered attention for its innovative approach to dental health, securing investments from key players in the healthcare and technology sectors. GreenMark's achievements include the successful development and market introduction of CrystLCare™, which has the potential to significantly reduce the need for invasive dental procedures. Overall, GreenMark Biomedical is making a substantial impact by setting new standards in preventative dental care.
Companies similar to GreenMark Biomedical include Crystalplex, NanoHybrids, Biomat Sciences and MNT Smartsolutions.
GreenMark Biomedical was founded in 2016.
GreenMark Biomedical's headquarters is located in East Lansing, MI, US.
As of Aug 28, 2023, GreenMark Biomedical has disclosed funding of $3.7M (USD). Undisclosed round amounts are excluded.
GreenMark Biomedical has 30 employees as of Feb 5, 2024.
